Immune dysfunction in murine polymicrobial sepsis: Mediators, macrophages, lymphocytes and apoptosis

Shock

Volumn 6, Issue 6 SUPPL., 1996, Pages

  Ayala, Alfred ^a,b,d   Chaudry, Irshad H ^a,c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Brown University ^*  (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; CYTOKINE; GLUCOCORTICOID; PROSTAGLANDIN E2;

ANIMAL; APOPTOSIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LIVER; LYMPHOCYTE; MACROPHAGE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PERITONEUM MACROPHAGE; PHYSIOLOGY; REVIEW; SEPSIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; CALCIUM; CYTOKINES; DINOPROSTONE; GLUCOCORTICOIDS; HUMANS; IMMUNE TOLERANCE; LIVER; LYMPHOCYTES; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; SEPSIS;

EID: 0029683518     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199610001-00007     Document Type: Article

References (134)

1. Baue AE: Multiple Organ Failure: Patient Care and Prevention. St. Louis: Mosby, 1990, pp 336-363.
2. Goris RJA: Sepsis and multiple organ failure: The result of whole body inflammation. In Faist E, Meakins J, Schildberg FW (eds): Host Defense Dysfunction in Trauma, Shock and Sepsis. Berlin-Heidelberg: Springer-Verlag, 1993, pp 161-170.
3. Marshall J, Sweeney D: Microbial infection and the septic response in critical surgical illness. Arch Surg 125:17-23, 1990.
4. Marshall JC: Immunologic dyshomeostasis in multiple organ failure: The gut-liver axis. In Faist E, Meakins J, Schildberg FW (eds): Host, Dysfunction in Trauma, Shock and Sepsis, Berlin-Heidelberg: Springer-Verlag, 1993, pp 243-252.
5. Baue AE: The horror autotoxicus and multiple-organ failure. Arch Surg 127:1451-1462, 1992.
6. Deitch EA: Multiple Organ Failure: Pathophysiology and potential future therapy. Ann Surg 216:117-134, 1992.
7. Friese RS, Rehring TF, Wollmering M, Moore EE, Ketch LL, Banerjee A, Harken AH: Trauma primes cells: editorial review. Shock 1:388-394, 1994.
8. Cerra FB: Hypermetabolism-organ failure syndrome: A metabolic response to injury. Crit Care Clinics 5:289-302, 1989.
9. Groeneveld AB, Bronsveld W, Thijs LG: Hemodynamic determinants of mortality in human septic shock. Surgery 99:140, 1986.
10. Lewis RA, Austen KF: Leukotrienes. In Gallin JI, Goldstein IM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates, New York: Raven Press, 1988, pp 121-128.
11. Hamilton TA, Adams DO: Molecular mechanisms of signal transduction in macrophages. Immunol Today 8:151-158, 1987.
12. Border J: Hypothesis: Sepsis, multiple systems organ failure, and the macrophage. Arch Surg 123:285-286, 1988.
13. Beutler B, Cerami A: The biology of cachectin/TNF: A primary mediator of the host response. Ann Rev Immunol 7:625-655, 1989.
14. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock: Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169:333-338, 1989.
15. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975-978, 1989.
16. Marks JD, Marks CB, Luce JM, Montgomery B, Turner J, Metz CA, Murray JF: Plasma tumor necrosis factor in patients with septic shock. Am Rev Respir Dis 141:94-97, 1990.
17. Marano MA, Fong Y, Moldawer LL, et al: Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 170:32-38, 1990.
18. van der Poll T, Lowry SF: Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock 3:1-12, 1995.
19. Maier RV: The "angry" macrophage and its impact on host response mechanisms. In Faist E, Meakins J, Schildberg F (eds): Host Defense Dysfunction in Trauma, Shock and Sepsis. Berlin-Heidelberg: Springer-Verlag, 1993, pp 191-197.
20. Marshall JC: Immunologic dyshomeostasis in multiple organ failure: The gut-liver axis. In Faist E, Meakins J, Schildberg F (eds): Host Defense Dysfunction in Trauma, Shock and Sepsis, Berlin-Heidelberg: Springer-Verlag, 1993, pp 245-252.
21. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophage to release inflammatory mediators (IL-1, IL-6 and TNF). Circ Shock 36: 191-199, 1992.
22. Ayala A, Knotts JB, Ertel W, Perrin MM, Morrison MH, Chaudry IH: Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis. Arch Surg 128:89-95, 1993.
23. Munoz C, Misset B, Fitting C, Bleriot JP, Cartel J, Cavaillon JM: Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol 21:2177-2184, 1991.
24. Munoz C, Carlet J, Fitting C, Misset B, Bleriot J-P, Cavaillon J-M: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747-1754, 1991.
25. 2+ signalling and proliferative responses during sepsis. Shock 1:466-471, 1994.
26. 2) in traumatized individuals. In Faist E, Meakins JL, Schildberg FW (eds): Host Defense Dysfunction in Trauma, Shock and Sepsis: Mechanisms and Therapeutic Approaches, Berlin: Springer-Verlag, 1993, pp 637-650.
27. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH: Polymicrobial sepsis but not low dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. J Surg Res 56:579-585, 1994.
28. 2 improves energetics and decreases lethality. J Surg Res 56:537-542, 1994.
29. Ayala A, Kisala JM, Felt JA, Perrin MM, Chaudry IH: Does endotoxin tolerance prevent the release of inflammatory monokines (IL-1, IL-6, or TNF) during sepsis? Arch Surg 127:191-197, 1992.
30. Ertel W, Morrison MH, Wang P, Ba ZF, Ayala A, Chaudry IH: The complex pattern of cytokines in sepsis: Association between prostaglandins, cachectin and interleukins. Ann Surg 214:141-148, 1991.
31. Hadjiminas DJ, McMasters KM, Peytort JC, Cheadle WG: Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin. J Surg Res 56:549-555, 1994.
32. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA: Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J Immunol 149:1666-1670, 1992.
33. Christou NV, MacLean L, Meakins JL: Host defense in blunt trauma: Interrelationships of kinetics of anergy and depressed neutrophil function: Nutritional status and sepsis. J Trauma 20:833-841, 1980.
34. Ayala A, Knotts JB, Lehman DL, Pierson CR, Patel P, Chaudry IH: Early administration of diltiazem is insufficient to block the late changes in splenocyte lymphokine release and total cell calcium induced by sepsis. FASEB J 7:A593, 1993 (Abstract).
35. 2+) during polymicrobial sepsis. FASEB J 5:A1102, 1991 (Abstract).
36. Gallinaro RN, Naziri W, McMasters KM, Peyton JC, Cheadle WG: Alteration of mononuclear cell immune-associated antigen expression, interleukin-1 expression, and antigen presentation during intra-abdominal infection. Shock 1:130-134, 1994.
37. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH: Does endotoxin play a major role in inducing the depression of macrophage function during polymicrobial sepsis? Arch Surg 130:1178-1185, 1995.
38. Mathison JC, Virca GD, Wolfson E, Tobias PS, Glaser K, Ulevitch RJ: Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest 85:1108-1118, 1990.
39. Hesse DG, Tracey KJ, Fong Y, et al: Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 166:147-153, 1988.
40. Zuckerman SH, Evans GF, Snyder YM, Roeder WD: Endotoxin-macrophage interaction: post-translation regulation of tumor necrosis factor expression. J Immunol 143:1223-1227, 1989.
41. 2) and interleukin 6 production. Shock 1:366-371, 1994.
42. Aasen AO: LPS plasma levels in patients. In Schlag G, Redl H (eds): Pathophysiology of Shock, Sepsis and Organ Failure. Berlin: Springer-Verlag, 1993, pp 417-426.
43. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE: Endotoxemia in human septic shock. Chest 99:169-175, 1991.
44. Van Deventer SJH, Buller HR, Ten Cate JW, Struk A, Pauw W: Endotoxemia: An early predictor of septicaemia in febrile patients. Lancet 1:605-609, 1988.
45. Chaudry IH, Ayala A, Singh G, Wang P, Hauptman JG: Rodent models of endotoxemia and sepsis. In Schlag G, Redl H (eds): Pathophysiology of Shock, Sepsis and Organ Failure. Berlin: Springer-Verlag, 1993, pp 1048-1059.
46. 2. Biochem Biophys Res Comm 137:404-410, 1986.
47. Sherry B, Cerami A: Mini-Review. Cachectin/TNF exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol 107:1269-1277, 1988.
48. McMasters KM, Peyton JC, Hadjiminas DJ, Cheadle WG: Endotoxin and tumour necrosis factor do not cause mortality from caecal ligation and puncture. Cytokine 6:530-536, 1994.
49. Kisala JM, Ayala A, Perrin MM, Stephan RN: Lethality and altered macrophage cytokine production following sepsis in endotoxin-tolerant mice. Circ Shock 27:304, 1989 (Abstract).
50. Faist E, Meakins J, Schildberg FW (eds): Host Defense Dysfunction in Trauma, Shock and Sepsis. Berlin-Heidelberg: Springer-Verlag, 1993, pp 1-1296.
51. Schlag G, Redl H (eds): Pathophysiology of Shock, Sepsis and Organ Failure. Berlin: Springer-Verlag, 1993, pp 1-1142.
52. Waage A, Halstensen A, Espevik T: Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet i:355-357, 1987.
53. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA: Interleukin-1 induces a shock like state in rabbits. Synergism with tumor necrosis factor and the effects of cyclooxygenase inhibition. J Clin Invest 81:1162-1172, 1988.
54. Tracey KJ, Beutler B, Lowry SF, et al: Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986.
55. Schirmer WJ, Schirmer JM, Fry DE: Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Arch Surg 124:445-448, 1989.
56. Deitch EA: Multiple organ failure: Summary and overview. In Deitch EA (ed): Multiple Organ Failure. New York: Thieme Medical Publishers, 1990, pp 285-299.
57. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG: Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 148:2724-2730, 1992.
58. Hadjiminas DJ, McMasters KM, Peyton JC, Cook MD, Cheadle WG: Passive immunization against tumor necrosis factor and interleukin-1 fails to reduce lung neutrophil sequestration in chronic sepsis. Shock 2:376-380, 1994.
59. Suffredini AF: Current prospects for the treatment of clinical sepsis. Crit Care Med 22:S12-S18, 1994.
60. Barriere SL, Lowry SF: An overview of mortality risk prediction in sepsis. Crit Care Med 23:376-393, 1995.
61. Ertel W, Scholl F, Steckholzer U, Trentz O: In vivo administration of Interleukin-10 attenuates the release of proinflammatory cytokines but causes suppression of cellular immunity in experimental sepsis. Arch Surg. In press.
62. Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641, 1990.
63. Wahl SM, McCartney-Francis N, Mergenhagen SE: Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today 10:258-261, 1989.
64. Miller-Graziano CL, Szabo G, Griffey K, Metha B, Kodys K, Catalano D: Role of elevated monocyte transforming growth factor beta (TGF-beta) production in posttrauma immunosuppression. J Clin Immunol 11:95-102, 1991.
65. Zhou D, Munster AM, Winchurch RA: Inhibitory effects of interleukin 6 on immunity: Possible implications in burn patients. Arch Surg 127:65-69, 1992.
66. Zhou D, Munster A, Winchurch RA: Pathologic concentrations of interleukin 6 inhibit T cell responses via induction of activation of TGF-beta. FASEB J 5:2582-2585, 1991.
67. Kunkel SL, Chensue SW, Phan SH: Prostaglandins as endogenous mediators of interleukin-1 production. J Immunol 136:186-192, 1986.
68. Kunkel SL, Remick DG, Strieter RM, Larrick JW: Mechanisms that regulate the production and effects of tumor necrosis factor-alpha. Crit Rev Immunol 9:93-117, 1989.
69. 2 acts at two distinct pathways of T-lymphocyte activation: Inhibition of interleukin-2 production and down-regulation of transferrin receptor expression. J Immunol 135:1172-1179, 1985.
70. 2 depresses antigen-presenting cell function of peritoneal macrophages. J Surg Res 44:733-739, 1988.
71. 2 on interferon-gamma induction of antigen presenting ability of P388D1 cells and on IL-2 production by T cell hybridoma. Cell Immunol 90:154-166, 1985.
72. Snyder DS, Beller DI, Unanue ER: Prostaglandins modulate macrophage Ia expression. Nature 299:163-165, 1982.
73. Garcia-Penarrubia P, Bankhurst AD, Koster FT: Prostaglandins from human T-suppressor/cytotoxic cells modulate natural killer antibacterial activity. J Exp Med 170:601-606, 1989.
74. Metz CA, Sheagren JN: Ibuprofen in animal models of septic shock. J Crit Care 5:206-212, 1990.
75. Ayala A, Herdon CD, Lehman DL, DeMaso CM, Ayala CA, Chaudry IH: The induction of accelerated thymic programmed cell death during polymicrobial sepsis: Control by corticosteroids but not tumor necrosis factor. Shock 3:259-267, 1995.
76. Gillis S, Crabtree GR, Smith KA: Glucocorticoid-induced inhibition of T-cell growth factor production: the effect on mitogen-induced lymphocyte proliferation. J Immunol 123:1624-1631, 1979.
77. Calvano SE: Glucocorticoid-immune system interactions in injury and sepsis. In Faist E, Meakins JL, Schildberg FW (eds): Host Defense Dysfunction in Trauma, Shock and Sepsis: Mechanisms and Therapeutic Approaches. Berlin: Springer-Verlag, 1993, pp 331-338.
78. Fertsch-Ruggio D, Schoenberg DR, Vogel SN: Induction of macrophage Ia antigen expression by rIFN-gamma and down-regulation by IFN-alpha/beta and dexamethasone are regulated transcriptionally. J Immunol 141:1582-1589, 1988.
79. Snyder DS, Unanue ER: Corticosteroids inhibit murine macrophage Ia expression and interleukin production. J Immunol 129:1803-1805, 1982.
80. Remick DG, Strieter RM, Lynch JP III, Nguyen D, Eskandari M, Kunkel SL: In vivo dynamics of murine tumor necrosis factor alpha gene expression. Kinetics of dexamethasone-induced suppression. Lab Invest 60:766-771, 1989.
81. Garvy BA, King LE, Telford WG, Morford LA, Fraker PJ: Chronic elevation of plasma corticosterone causes reductions in the number of cycling cells of the B lineage in murine bone marrow and induces apoptosis. Immunology 80:587-592, 1993.
82. Garvy BA, Telford WG, King LE, Fraker PJ: Glucocorticoids and irradiation-induced apoptosis in normal murine bone marrow B-lineage lymphocytes as determined by flow cytometry. Immunology 79:270-277, 1993.
83. Hoffman RA, Langrehr JM, Billiar TR, Curran RD, Simmons RL: Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol 145:2220-2226, 1990.
84. Albina JE, Abate JA, Henry WL Jr: Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. J Immunol 147:144-148, 1991.
85. Lejeune P, Lagadec P, Onier N, Pinnard D, Ohshima H, Jeannin JF: Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 152:5077-5083, 1994.
86. Albina JE, Cui S, Mateo RB, Reichner JS: Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150:5080-5085, 1993.
87. Sicher SC, Vazquez MA, Lu CY: Inhibition of macrophage Ia expression by nitric oxide. J Immunol 153:1293-1300, 1994.
88. Schwartz LM, Osborne BA: Programmed cell death, apoptosis and killer genes. Immunol Today 14:582-590, 1993.
89. Cohen JJ, Duke RC, Fadok VA, Sellins KS: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267-293, 1992.
90. Arends MJ, Wyllie AH: Apoptosis: mechanisms and roles in pathology, Int Rev Exp Pathology 32:223-254, 1991.
91. Barr PJ, Tomei LD: Apoptosis and its role in human disease. Biol Technology 12:487-493, 1994.
92. Lockshin RA, Williams CM: Programmed cell death. I J Insect Physiol 11:123-133, 1965.
93. Furuya Y, Berges R, Lundmo P, Isaacs JT: Cell proliferation, p53. Gene expression, and intracellular calcium in programmed death: Prostate model. In Inglis J, Witkowski JA (eds): Apoptosis II. The Molecular Basis of Apoptosis in Disease. Plainview, NY: Cold Spring Harbor Lab Press, 1994, pp 231-252.
94. Rabizadeh S, Oh J, Zhong L-T, Yang J, Bitler CM, Butcher LL, Bredesen DE: Induction of apoptosis by the low-affinity NGF receptor. Science 261:345-348, 1993.
95. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845-853, 1993.
96. + T cell-mediated cytotoxicity. J Immunol 152:1127-1133, 1994.
97. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on fas antigen-mediated cell death. J Immunol 151:621-627, 1993.
98. Zubiaga AM, Munoz E, Huber BT: IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. J Immunol 149:107-112, 1992.
99. Migliorati G, Nicoletti I, Pagliacii MC, D'Adamio L, Riccardi C: Interleukin-4 protects double-negative and CD4 single-positive thymocytes from dexamethasone-induced apoptosis. Blood 81:1352-1358, 1993.
100. Lotem J, Sachs L: Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 80:1750-1757, 1992.
101. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T: Analysis of the survival of mature human eosinophils: Interleukin-5 prevents apoptosis in mature human eosinophils. Blood 78:2542-2547, 1991.
102. Eischen CM, Dick CJ, Leibson PJ: Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 153:1947-1953, 1994.
103. Orchansky PL, Teh H-S: Activation-induced cell death in proliferating T cells is associated with altered tyrosine phosphorylation of TCR/CD3 subunits. J Immunol 153:615-622, 1994.
104. Ong CJ, Chui D, Teh H-S, Marth JD: Thymic CD45 tyrosine phosphatase regulates apoptosis and MHC-restricted negative selection. J Immunol 152:3793-3805, 1994.
105. Sikora E, Grassilli E, Radziszewska E, Bellesia E, Barbieri D, Franceschi C: Transcription factors DNA-binding activity in rat thymocytes undergoing apoptosis after heat-shock or dexamethasone treatment. Biochem Biophys Res Comm 197:709-715, 1993.
106. Gruol DJ, Altschmied J: Synergistic induction of apoptosis with glucocorticoids and 3′,5′-cyclic adenosine monophosphate reveals agonist activity by RU 486. Mol Endrocrinology 7:104-113, 1993.
107. 2+ concentration. Arch Biochem Biophys 269: 365-370, 1989.
108. Barrett JC, Preston G: Apoptosis and cellular senescence: Forms of irreversible growth arrest. In Inglis J, Witkowski JA (eds): Apoptosis II. The Molecular Basis of Apoptosis in Disease, Plainview, NY: Cold Spring Harbor Lab. Press, 1994, pp 253-281.
109. Kabelitz D, Pohl T, Pechhold K: Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 14:338-339, 1993.
110. Hernández-Caselles T, Stutman O: Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. J Immunol 151:3999-4012, 1993.
111. Cohen JJ: Glucocorticoid-induced apoptosis in the thymus. Immunology 4:363-369, 1992.
112. Zhang Y-H, Takahashi K, Jiang G-Z, Kawai M, Fukada M, Yokochi T: In vivo induction of apoptosis (programmed cell death) in mouse thymus by administration of lipopolysaccharide. Infect Immun 61:5044-5048, 1993.
113. Mastino A, Grelli S, Piacentini M, Oliverio S, Favalli C, Perno CF, Garaci E: Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV. Cell Immunol 152:120-130, 1993.
114. Juzan M, Hostein I, Gualde N: Role of thymus-eicosanoids in the immune response. Prostaglandins Leukot Essent Fatty Acids 46:247-255, 1992.
115. Rotello RJ, Lieberman RC, Purchio AF, Gerschenson LE: Coordinated regulation of apoptosis and cell proliferation by TGF-β1 in cultured cell. Proc Natl Acad Sci USA 88:3412-3415, 1991.
116. Fluckiger A-C, Durand I, Banchereau J: Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 179:91-99, 1994.
117. Schlag G, Redl H (eds): Pathophysiology of Shock, Sepsis, and Organ Failure. Berlin-Heidelberg: Springer-Verlag, 1993, pp 1-1165.
118. Chaudry IH, Ayala A: Immunological Aspects of Hemorrhage. Austin, TX: Medical Intelligence Unit; R. G. Landes Company, 1992, pp 1-132.
119. Chaudry IH, Ayala A, Ertel W, Stephan RN: Editorial Review. Hemorrhage and resuscitation: Immunological Aspects. Am J Physiol 259: R663-R678, 1990.
120. Wang S-D, Huang K-J, Lin Y-S, Lei H-Y: Sepsis-induced apoptosis of the thymocytes in mice. J Immunol 152:5014-5021, 1994.
121. Ayala A, Lehman DL, Herdon CD, Childers HA, Chaudry IH: Sepsis induces programmed cell death in bone marrow as well as thymocytes. Shock 1 (Supplement):21, 1994 (Abstract).
122. +) population. Shock 3:36, 1995 (Abstract).
123. Ayala A, Herdon CD, Chaudry IH: Polymicrobial sepsis induces apoptosis in mucosal lymphoid B-cells but not in helper T-cells. FASEB J 9:A1033, 1995 (Abstract).
124. Haslett C: Resolution of acute inflammation and the role of apoptosis in the tissue. Clin Sci Colch 83:639-648, 1992.
125. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012-2020, 1992.
126. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C: Macrophage phagocytosis of aging neutrophils in inflammation. J Clin Invest 83:865-875, 1989.
127. Savill J, Fadok V, Henson P, Haslett C: Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131-135, 1993.
128. Biffl WL, Moore FA, Carl VS, Moore EE, Banerjee A, Peterson VM: Interleukin-6 delays neutrophil apoptosis. Arch Surg. 131:24-29, 1996.
129. Biffl WL, Moore EE, Moore FA, Barnett Jr, CC, Carl VS, Peterson VM: Interleukin-6 (IL-6) delays neutrophil (PMN) apoptosis via a mechanism involving platelet-activating factor (PAF). J Trauma 40:575-579, 1996.
130. Imaizumi T-A, Stafforini DM, Yamada Y, McIntyre TM, Prescott SM, Zimmerman GA: Platelet-activating factor: A mediator for clinicians. J Internal Med 238:5-20, 1995.
131. Mangan DF, Welch GR, Wahl SM: Lipopolysaccharide, tumor necrosis factor-α and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol 146:1541-1546, 1991.
132. Sarih M, Souvannavong V, Adam A: Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Comm 191:503-508, 1993.
133. Hogquist KA, Nett MA, Unanue ER, Chaplin DD: Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 88: 8485-8489, 1991.
134. o) associated with macrophage (MΔ) dysfunction? J Trauma 40:568-574, 1996.